Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study)

IntroductionLittle is known about the first line induction chemotherapy cycles for HIV-associated diffuse large B-cell lymphoma (DLBCL) as these are less common than HIV-negative lymphoma. Currently, the optimal treatment cycles option remains undefined. Therefore, we performed a multi-center study...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Chaoyu Wang, Yan Wu, Jun Liu, Haiyan Min, Yunhong Huang, Guo Wei, Wei Zhang, Min Wang, Xiaoqiong Tang, Hui Zhou, Yaokai Chen, Yao Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Subjects:	HIV DLBCL prognosis chemotherapy cycles CALL
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1153790/full